RecruitingNot ApplicableNCT07120087

Evaluation of an Online Intervention to Educate Women at High Risk of Breast Cancer on How to Help Reduce Their Risk.

Evaluation of a Virtual Risk-reduction Intervention Among Women at Higher Than Average Risk of Breast Cancer in the European MyPeBS Screening Trial


Sponsor

UNICANCER

Enrollment

1,508 participants

Start Date

Feb 19, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Breast cancer remains the most common cancer among women and a major cause of death despite advances in screening and treatment. Current screening programs are not personalized and are experiencing declining participation. A promising strategy for breast cancer control would be to implement risk-based prevention and early screening, targeting individuals at high risk of developing breast cancer, in order to improve chances of cure and reduce the need for more intensive treatments. The MyPeBS study was designed to assess whether personalized breast cancer screening (based on an individual's risk of developing breast cancer) is as effective as, or more effective than, current standard screening. Lifestyle interventions involving changes in diet or physical activity, for example, have been shown to be effective in reducing the risk of developing breast cancer, whether low or high. The MyPeBS study evaluates personalized screening but offers limited information on breast cancer prevention. MyPREV is a project that aims to assess the feasibility and impact of a personalized online program on breast cancer risk reduction measures. This program is offered to women at high risk of developing breast cancer as part of the European MyPeBS screening study. The main objective is to evaluate adherence to a personalized, online breast cancer prevention program focused on lifestyle and its acceptance among women at high or very high risk of developing cancer who participated in the MyPeBS study.


Eligibility

Sex: FEMALEMin Age: 40 YearsMax Age: 74 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing an online education program to help women who are at high risk for breast cancer understand and take steps to reduce that risk. **You may be eligible if...** - You are female (or identify as female), aged 40–74 - You have participated in the MyPeBS breast cancer screening study - You were assessed as being at high risk (≥1.67%) or very high risk (≥6%) of developing invasive breast cancer within 5 years - You are willing to participate in the online intervention **You may NOT be eligible if...** - You were diagnosed with breast cancer during your follow-up in the MyPeBS study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALIntervention

Virual Webinar and online personalised clinical visit


Locations(3)

Centre Médical et Dentaire de Lyon MGEN

Lyon, France

Gustave Roussy

Villejuif, France

AOU Città della Salute e della Scienza - CPO PiedmontSSD Epidemiologia e Screening

Torino, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07120087


Related Trials